MDD patients exhibit significantly elevated levels of CRP, IL-6, and Tumor necrosis factor-alpha (TNF-α) in their plasma compared to healthy individuals, which significantly decreased after 8 weeks of SSRI treatment [18,19]. The gene discussed is IL6; the disease is major depressive disorder.